Skip to content

Read how Javara and Privia Health are aligning to integrate clinical trials into the patient continuum of care. 

Chie Mushayamunda

JAVARA AND PRIVIA HEALTH ALIGN TO INTEGRATE CLINICAL TRIALS INTO THE PATIENT CARE CONTINUUM

By Chie Mushayamunda / November 13, 2019

ATLANTA, HOUSTON, WASHINGTON AND WINSTON-SALEM, NC — Javara and Privia Health, one of the nation’s fastest growing primary care focused medical groups providing value-based care to its patients, are aligning to offer industry-sponsored clinical trials to Privia Medial Group – Gulf Coast and Privia Medical Group – Georgia patients. Privia Health partners with national medical…

Read More

What’s a ‘Myocardial Infarction’?

By Chie Mushayamunda / August 28, 2019

Closing the gap in clinical research participation through addressing health literacy Do you know what myocardial infarction means? In more simple terms, it’s a heart attack. Myocardial infarction and heart attack mean the same thing, yet one is more likely to be understood by the general population than the other. Terms like myocardial infarction, hyperlipidemia…

Read More

JAVARA AND TRYON MEDICAL PARTNERS WORKING TOGETHER TO BUILD A ROBUST CLINICAL TRIALS OFFERING

By Chie Mushayamunda / August 1, 2019

CHARLOTTE AND WINSTON-SALEM, NC — Javara and Tryon Medical Partners today announced that they have formed a collaboration to offer industry-sponsored, outpatient clinical trials to Tryon Medical Partners’ patients. “This partnership is a win-win for both our patients and doctors,” said Dr. Dale Owen, CEO of Tryon Medical Partners and a cardiologist with the practice. …

Read More

On the Highway to Access: Innovation in Awareness, Education and Transportation in Clinical Research

By Chie Mushayamunda / June 12, 2019

Lack of reliable transportation has increasingly become a barrier to patients having access to and receiving consistent healthcare. In the span of a year, it costs the United States’ healthcare system more than $150 billion as a result of missed patient appointments. The burden of missing an appointment often leads to frustration and dissatisfaction when…

Read More

Navigating Clinical Trials

By Chie Mushayamunda / May 30, 2019

Harvard Business Review reports that 26% of patients who face chronic or serious conditions have a low understanding of how to navigate the healthcare system. Similar to a complex healthcare system, the clinical trial process can be overwhelming to prospective research participants.  Javara believes there is a solution, the Clinical Trial Navigator (CTN).  Historically, this…

Read More

CRAACO 2019 Recap

By Chie Mushayamunda / May 9, 2019

Clinical research as a care option was founded on the premise of integrating clinical research as part of the patient care continuum to enhance health outcomes, reduce costs, and enhance the patient and provider experience. The CRAACO Conference provides a space for individuals to learn more about why we should deploy clinical research as a…

Read More

Language Matters – Bridging the Health Literacy Gap

By Chie Mushayamunda / May 8, 2019

Nearly 90 million people in the U.S. have difficulty understanding and acting upon health information, which affects their ability to make informed healthcare decisions. Health literacy affects an array of medical decisions, from dietary choices, to major decisions like which cancer treatment plan to pursue. People everyday make decisions about their health or the health…

Read More

Javara Launches Rides with Uber Health to Transcend the Barrier of Transportation for Clinical Trial Patients

By Chie Mushayamunda / March 25, 2019

Winston-Salem, North Carolina – Javara Inc., has announced the launch of Uber Health rides for patients to expand access to clinical research.  The initiative with Uber Health, the HIPAA-compliant technology solution from Uber, is centered around improving care options for patients by increasing clinical trial access and flexibility, aligning with Javara’s mission to improve the…

Read More

DPharm 2018’s Impact: A Call to Innovate

By Chie Mushayamunda / October 9, 2018

DPharm 2018 was all about a community of innovators coming together to discuss their disruptive ideas that will transform the norm of clinical research and biopharma development ultimately, to the benefit of patients. It’s clear as we look throughout the world around us, the pace of innovation is accelerating. What it affects is not selective…

Read More

Javara and Wake Forest Baptist Medical Center Sign Letter of Intent to Design an Operating Model to Advance Patient Access to Clinical Trials

By Chie Mushayamunda / September 25, 2018

Winston-Salem, North Carolina – Javara Inc., and Wake Forest Baptist Medical Center (WFBMC) announce they have signed a letter of intent to design a fully integrated operating model that will expand integration of industry-sponsored clinical trials to patients for whom WFBMC serves, making clinical trials more accessible. Javara is pleased to offer WFBMC the additional…

Read More